NEW:  Researchers at the Warsaw Zoo in Poland have launched a project to check whether cannabis-extract oil will reduce anxiety in the zoo's elephants. For more information:

https://www.cnn.com/2020/08/27/europe/elephants-stressed-cbd-poland-scli-intl-scn/index.html

https://www.bbc.com/news/world-europe-53907689

________________________________

NEW: CannPal announces completion of its safety and efficacy study on Dermacann®, which reduces atopic dermatitis symptoms in dogs.  For more information: 

https://hempgazette.com/news/cannpal-cbd-dogs-hg1224/

For preliminary results, see the announcement freely accessible online by clicking the link in the above press release, or directly below:

http://cannpal.listedcompany.com/newsroom/20200721_44kpjjlhm8r3bz.pdf

_________________________________________

NEW: Tarleton State University’s Equine Center, part of the Texas A & M University system, seeks to quantify how CBD affects inflammation, stress and stereotypical negative behaviors in horses.  For more information:

https://today.tamu.edu/2020/02/12/hemp-for-horses-tarleton-researcher-investigating-benefits/

___________________________________________

University of Saskatchewan's Western College of Veterinary Medicine will undertake research to study whether cannabis can be used to prevent chronic vomiting in dogs and cats.  For more information:

https://wcvmtoday.usask.ca/articles/2019/11/scientists-probe-cannabis-potential-as-anti-vomiting-therapy-for-pets.php

_______________________________________________

University of Guelph will undertake a three-year study exploring the efficacy of cannabis for treating bladder cancer in dogs.  For more information:

https://news.uoguelph.ca/2019/10/u-of-g-researcher-investigating-cannabis-as-treatment-for-animal-cancer/

_______________________________________________

CannPal progressing canine cannabinoid trials.  (Phase 2A pilot dose determination study for canine osteoarthritis and DermaCann trial starting soon.) For more information:

https://hempgazette.com/news/cannpal-cannabis-trials-hg0971/

_____________________________________________

Penn Vet to study hemp-based supplement. For more information:

https://www.veterinarypracticenews.com/penn-vet-study-hemp-based-canine-supplement/

_______________________________________________

Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals.  For more information:

https://www.canopygrowth.com/wp-content/uploads/2018/08/20180802_CAH-Anxiety-Study-NR-Final-EN-1.pdf


CannPal Animal Therapeutics commences Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived pain control for dogs.  For more information:

https://www.americanveterinarian.com/news/first-cannabinoid-animal-drug-garners-favorable-study-results

*Click this link for a press release regarding preliminary results on this study. (At the bottom, there is a freely accessible link to the results presentation and research abstract from the 2019 Australian Veterinary Association)

https://www.invetus.com/latest-news/2019/5/15/cannpal-presents-results-on-medicinal-cannabinoids-for-dogs